Capitolis Advisors’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
Other funds holding JNJ
Capitolis Advisors's JNJ Position: Q3 2022 in Review
Capitolis Advisors sold out of Johnson & Johnson (JNJ) in Q3 2022, closing a stake of 502,000 shares — an estimated $89.1M sold.
Capitolis Advisors first reported a position in JNJ in Q4 2020 and held it in 7 quarters. The position peaked at $127M in Q4 2021. 3,622 funds tracked by Wall St. Rank hold JNJ as of Q3 2022.
- Capitolis Advisors reported no remaining Johnson & Johnson position as of Q3 2022 after selling out during the quarter.
- Capitolis Advisors sold 502,000 Johnson & Johnson shares in Q3 2022, an estimated $89.1M.
- Capitolis Advisors first reported a position in Johnson & Johnson in Q4 2020 and held it in 7 quarters.
- Capitolis Advisors's Johnson & Johnson position peaked at $127M in Q4 2021.
- 3,622 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2022.
Based on Capitolis Advisors's 13F filing for Q3 2022, filed 10 Nov 2022.